This report contains market size and forecasts of Gynecological Nursing Drugs in global, including the following market information:
- Global Gynecological Nursing Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Gynecological Nursing Drugs Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Gynecological Nursing Drugs companies in 2022 (%)
The global Gynecological Nursing Drugs market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Contraception Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Gynecological Nursing Drugs include Amgen Inc., F. Hoffmann La Roche Ltd, Novartis AG, Bayer AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories and AbbVie Inc., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gynecological Nursing Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gynecological Nursing Drugs Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Gynecological Nursing Drugs Market Segment Percentages, by Type, 2022 (%)
- Contraception
- Gynecological Infection
- Female Infection
- Postmenopausal Disease
- Gynecological Cancer
- Endometriosis
Global Gynecological Nursing Drugs Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Gynecological Nursing Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Institute of Medicine
- Clinic
- Others
Global Gynecological Nursing Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Gynecological Nursing Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Gynecological Nursing Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Gynecological Nursing Drugs revenues share in global market, 2022 (%)
- Key companies Gynecological Nursing Drugs sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Gynecological Nursing Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Amgen Inc.
- F. Hoffmann La Roche Ltd
- Novartis AG
- Bayer AG
- Merck & Co., Inc.
- Eli Lilly and Company
- Pfizer Inc.
- Abbott Laboratories
- AbbVie Inc.
- GlaxoSmithKline Plc
- AstraZeneca Plc
- Lupin Limited
- Johnson and Johnson
- Sanofi SA
- Ferring Pharmaceuticals
